- Education
-
Research
Current research
Talent
-
Collaboration
Businesses
Government agencies and institutions
Alumni
-
About AU
Organisation
Job at AU
Targeting members of the TGFβ superfamily to achieve bone and skeletal muscle anabolism
2021.08.20 |
| Date | Fri 27 Aug |
| Time | 14:00 — 16:00 |
| Location | "Det Blå Auditorium", the Viktor Albeck building, Vennelyst Blvd. 4, Aarhus University |
On Friday 27 August at 14.00, Andreas Lodberg defends his PhD dissertation entitled "Targeting members of the TGFβ superfamily to achieve bone and skeletal muscle anabolism".
Bone loss and muscle wasting are two conditions that often coincide. Both conditions may lead to severe disability and morbidity. For hip fractures, the first-year mortality rate is a staggering 30% and new therapies are therefore urgently needed to improve patient outcomes. Three members of the TGFβ superfamily: activin A, growth differentiation factor 11, and myostatin have emerged as promising therapeutic targets in musculoskeletal disease. A new PhD project from Aarhus University, Health has investigated inhibition of these growth factors to combat musculoskeletal wasting in mouse models.
The summary is written by the PhD student.
The defence is public and takes place in "Det Blå Auditorium", the Viktor Albeck building, Vennelyst Blvd. 4, Aarhus University. Please read full press release.
PhD student Andreas Lodberg
Mail: andreas@biomed.au.dk
Phone: (+45) 53659060